Advancing science to transform medicine
BioNTech is a global biopharmaceutical company pioneering novel investigative therapies for cancer and infectious diseases. We are committed to transforming how cancer is treated. With more than 15 years of immunology and technological expertise, our ambition is to develop medicines that work together to treat cancer from multiple angles – training the immune system to recognize cancer more effectively, addressing multiple disease drivers, and targeting tumor cells with precision.
Our diversified portfolio includes mRNA cancer immunotherapies, next-generation immunomodulators, and targeted therapies such as antibody-drug conjugates. These complementary modalities are designed to address the full spectrum of cancer, from early-stage disease with high risk of recurrence to advanced and metastatic cancers.
We are advancing science to deliver tomorrow’s breakthroughs today.
Annual report
In 2024, BioNTech achieved significant progress, with priority programs progressing into late-stage development and enhanced AI capabilities. Access our annual report for the year 2024 for insights into corporate and scientific milestones, comprehensive pipeline updates and a summary of our financial results.
Download the 2024 annual report
15 MB / PDF
Explore more about BioNTech
Our board members
Meet the leaders driving our efforts to leverage the immune system to develop treatments for diseases with unmet and/or high medical need.
Our collaborators
Discover how our partnerships and collaborations with a number of the world’s most established biotechnology and pharmaceutical companies, academia and non-profit organizations help us drive medical breakthroughs and therapeutic innovations to improve standard of care.
Our sites and subsidiaries
BioNTech’s global site network integrates capabilities from discovery to delivery that fuel the research, development and commercialization of novel immunotherapies and vaccines.
Our corporate sustainability and responsibility
Find out how BioNTech’s commitment to innovation, transparency, and sustainability supports global health and responsible governance.
